IL-21-dependent stimulation of functional intra-tumoral CD8+ cells was able to overcome the checkpoint blockade resistance in renal cancer and enhanced the antitumor activity of tumor-infiltrating lymphocytes [157]. The gene discussed is CD8A; the disease is neoplasm.